Tardio Jason - Insider Non-Derivative Transactions at Ovid Therapeutics Inc. (OVID) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 22, 2024, Tardio Jason's relationship to Ovid Therapeutics Inc. (OVID) is Officer (Chief Operating Officer), and currently has 28,125 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other OVID insiders.
Data Source: SEC.
Tardio Jason - Insider Non-Derivative Transactions at OVID
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 23, 2024 | Acquisition -- (Common Stock) | 28125 | 0 | 28125 |